IRON DEFICIENCY WITHOUT ANEMIA IN COPD PATIENTS: ASSESSING EXERCISE CAPACITY AND EXACERBATION FREQUENCY
Keywords:
Chronic Obstructive Pulmonary Disease (COPD), Iron Deficiency, Non-Anaemic Iron Deficiency (NAID), COPD Exacerbations, Exercise Capacity in COPD, COPD Management Strategies.Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a global health challenge with significant morbidity and mortality. Iron deficiency, including non-anaemic iron deficiency (NAID), has been identified as a potential comorbid in COPD, affecting patient outcomes and disease severity. This study aimed to investigate the prevalence and impact of iron deficiency on the severity and clinical outcomes in COPD patients. Methods: In this descriptive cross-sectional study, 289 individuals diagnosed with COPD were enrolled and underwent comprehensive medical assessments, including haematological tests and spirometry from December 2019 to December 2023. The study focused on measuring iron levels, exercise capacity, and exacerbation frequency, comparing iron-deficient and non-iron-deficient groups. Results: The study found that 46.7% of participants had iron deficiency. Those with iron deficiency showed significantly lower exercise capacity as measured by the six-minute walk distance and experienced a higher frequency of yearly COPD exacerbations. However, no significant differences were observed in airflow limitation and the overall quality of life between the iron-deficient and non-iron-deficient groups. Conclusion: The findings suggest that iron deficiency, particularly NAID, is associated with a more severe progression of COPD, characterized by reduced exercise capacity and increased exacerbation frequency. These results highlight the importance of considering iron deficiency in the management of COPD to potentially improve patient outcomes. Keywords: Chronic Obstructive Pulmonary Disease (COPD); Iron Deficiency; Non-Anaemic Iron Deficiency (NAID); COPD Exacerbations; Exercise Capacity in COPD; COPD Management StrategiesReferences
Rehman AU, Muhammad SA, Tasleem Z, Alsaedi A, Dar M, Iqbal MO, et al. Humanistic and socioeconomic burden of COPD patients and their caregivers in Malaysia. Sci Rep. 2021;11(1):22598.
Hanafi NS, Agarwal D, Chippagiri S, Brakema EA, Pinnock H, Sheikh A, et al. Chronic respiratory disease surveys in adults in low- and middle-income countries: A systematic scoping review of methodological approaches and outcomes. J Glob Health. 2021;11:04026.
Brakema EA, Vermond D, Pinnock H, Lionis C, Kirenga B, An PL, et al. Implementing lung health interventions in low- and middle-income countries: a FRESH AIR systematic review and meta-synthesis. Eur Respir J. 2020;56(1):2000127.
Saeed S, Siddiqui M, Altaf R. The Obstructive Lung Diseases Program: Integrated obstructive lung disease services within primary care in Pakistan. Pak J Med Sci. 2022;38(2):334–9.
Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, et al. It is time for the world to take COPD seriously: a statement from the GOLD board of directors. Eur Respir J. 2019;54(1):1900914.
Amir Khan M, Ahmar Khan M, Walley JD, Khan N, Imtiaz Sheikh F, Ali S, et al. Feasibility of delivering integrated COPD-asthma care at primary and secondary level public healthcare facilities in Pakistan: a process evaluation. BJGP Open. 2019;3(1):bjgpopen18X101632.
Natali D, Cloatre G, Hovette P, Cochrane B. Screening for comorbidities in COPD. Breathe. 2020;16(1):190315.
Ito H, Kurokawa H, Matsui H. Mitochondrial reactive oxygen species and heme, non-heme iron metabolism. Arch Biochem Biophys. 2021;700:108695.
Ghio AJ, Soukup JM, Dailey LA, Madden MC. Air pollutants disrupt iron homeostasis to impact oxidant generation, biological effects, and tissue injury. Free Radic Biol Med. 2020;151:38–55.
Girelli D, Marchi G, Busti F, Vianello A. Iron metabolism in infections: Focus on COVID-19. Semin Hematol. 2021;58(3):182–7.
Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res. 2020;21(1):276.
Krishnan A, Turner AM. Chronic Obstructive Pulmonary Disease: The Present and Future. Biomedicines. 2022;10(2):499.
Kaur M, Chandel J, Malik J, Naura AS. Particulate matter in COPD pathogenesis: an overview. Inflamm Res. 2022;71(7–8):797–815.
Aghapour M, Ubags ND, Bruder D, Hiemstra PS, Sidhaye V, Rezaee F, et al. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD. Eur Respir Rev. 2022;31(163):210112.
Ghio AJ, Pavlisko EN, Roggli VL, Todd NW, Sangani RG. Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis. Int J Chron Obstruct Pulmon Dis. 2022;Volume 17:117–40.
Marques O, Weiss G, Muckenthaler MU. The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation. Blood. 2022;140(19):2011–23.
Baker JM, Hammond M, Dungwa J, Shah R, Montero-Fernandez A, Higham A, et al. Red Blood Cell-Derived Iron Alters Macrophage Function in COPD. Biomedicines. 2021;9(12):1939.
Sonnweber T, Pizzini A, Tancevski I, Löffler-Ragg J, Weiss G. Anaemia, iron homeostasis and pulmonary hypertension: a review. Intern Emerg Med. 2020;15(4):573–85.
Ulrich A. Genetic investigations of causality in disease applied to iron deficiency in pulmonary arterial hypertension. 2020 [cited 2024 Jan 8]; Available from: http://spiral.imperial.ac.uk/handle/10044/1/86966
Rathi V, Ish P, Singh G, Tiwari M, Goel N, Gaur SN. Iron deficiency in non-anemic chronic obstructive pulmonary disease in a predominantly male population: an ignored entity. Monaldi Arch Chest Dis. 2020;90(1):38–42.
Sarkar M, Rajta PN, Khatana J. Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact. Lung India Off Organ Indian Chest Soc. 2015;32(2):142–51.
John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest. 2005;127(3):825–9.
Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc CE. 2006;4:17.
Parveen S, Rangreze I, Ahmad SN, Mufti SA, Khan SS. Prevalence of anemia in patients with COPD and its potential impact on morbidity of COPD patients. Int J Clin Med. 2014;5(08):452–8.
Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin. 2008;24(4):1123–30.
John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006;111(3):365–70.
AMIN I, MUEEN H, AMIN H. Frequency of anemia in patients with chronic obstructive pulmonary disease (COPD). J Med Physiol Biophys. 2018;40:44–7.
Malik AA, Anwar S, Batool H, Karamat A, Ali G, Siddiqui F. Frequency of Anemia in Patients Presented with Chronic Obstructive Pulmonary Disease. Pak J Med Health Sci. 2022;16(4):239–40.
Abro AKDS, Saleem Q, Zain N, Memon KA, Abbassi a. Frequency of anemia in chronic obstructive pulmonary disease patients in tertiary care hospital karachi. J Peoples Univ Med Health Sci NawabshahJPUMHS. 2021;11(2):77–81.
30. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Spain; 2019 [cited 2024 Jan 8] p. 155. (GOLD). Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf
Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.
Chhabra S, Kumar R, Gupta U, Rahman M, Dash D. Prediction equations for spirometry in adults from northern India. Indian J Chest Allied Sci. 2014;56(4):221–9.
ATS statement: guidelines for the six-minute walk test. ATS committee on proficiency standards for clinical pulmonary function laboratories. Am J Respir Crit Care Med. 2002;166(1):111–7.
GlaxoSmithKline Services. COPD Assessment Test. 2022 [cited 2024 Jan 8]. Patient Site Test Page Urdu India. Available from: https://www.catestonline.org/patient-site-test-page-urdu.html
Philip KEJ, Sadaka AS, Polkey MI, Hopkinson NS, Steptoe A, Fancourt D. The prevalence and associated mortality of non‐anaemic iron deficiency in older adults: a 14 years observational cohort study. Br J Haematol. 2020;189(3):566–72.
Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency: FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008;51(2):103–12.
Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood J Am Soc Hematol. 2010;116(23):4754–61.
Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128(3):1201–8.
Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD J Chronic Obstr Pulm Dis. 2005;2(1):125–9.
Haas JD, Brownlie IV T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131(2):676S-690S.
Cote C, Zilberberg M, Mody S, Dordelly L, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–9.
Barberan‐Garcia A, Rodríguez DA, Blanco I, Gea J, Torralba Y, Arbillaga‐Etxarri A, et al. Non‐anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD. Respirology. 2015;20(7):1089–95.
Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012;653–61.
Hurst JR, Anzueto A, Vestbo J. Susceptibility to exacerbation in COPD. Lancet Respir Med. 2017;5(9):e29.
Ruiter G, Lankhorst S, Boonstra A, Postmus P, Zweegman S, Westerhof N, et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J. 2011;37(6):1386–91.
Yeo TJ, Yeo PSD, Ching‐Chiew Wong R, Ong HY, Leong KTG, Jaufeerally F, et al. Iron deficiency in a multi‐ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. Eur J Heart Fail. 2014;16(10):1125–32.
Plesner LL, Schoos MM, Dalsgaard M, Goetze JP, Kjøller E, Vestbo J, et al. Iron deficiency in COPD associates with increased pulmonary artery pressure estimated by echocardiography. Heart Lung Circ. 2017;26(1):101–4.
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–48.
Published
Issue
Section
License
Copyright (c) 2024 Munir Ahmad Abbasi, Aamir Nazir, Sadaf Anwar Qureshi, Nadia Haleem, Naheed Khattak, Muhammad Adnan Rashid
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
